FibroGen SG&A Expense (Quarterly) Analysis

FibroGen Inc (FGEN)

1.30 +0.02 (+1.56%) USD | NASDAQ | May 24, 16:00

1.30 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	22.82M
December 31, 2023	24.22M
September 30, 2023	25.57M
June 30, 2023	31.18M
March 31, 2023	34.28M
December 31, 2022	33.97M
September 30, 2022	29.90M
June 30, 2022	30.26M
March 31, 2022	30.56M
December 31, 2021	34.74M
September 30, 2021	25.85M
June 30, 2021	32.55M
March 31, 2021	30.78M
December 31, 2020	42.25M
September 30, 2020	-48.98M
June 30, 2020	63.54M
March 31, 2020	49.60M
December 31, 2019	50.71M
September 30, 2019	35.82M
June 30, 2019	26.74M
March 31, 2019	22.21M
December 31, 2018	17.85M

Date	Value
September 30, 2018	15.36M
June 30, 2018	15.06M
March 31, 2018	15.55M
December 31, 2017	13.85M
September 30, 2017	12.95M
June 30, 2017	13.42M
March 31, 2017	11.53M
December 31, 2016	12.58M
September 30, 2016	11.65M
June 30, 2016	10.38M
March 31, 2016	11.42M
December 31, 2015	12.96M
September 30, 2015	11.24M
June 30, 2015	9.68M
March 31, 2015	10.48M
December 31, 2014	12.82M
September 30, 2014	10.14M
June 30, 2014	7.516M
March 31, 2014	6.432M
December 31, 2013	7.911M
September 30, 2013	6.888M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

-48.98M

Minimum

Sep 2020

63.54M

Maximum

Jun 2020

30.32M

Average

30.98M

Median

SG&A Expense (Quarterly) Benchmarks